Sign Up to like & get
recommendations!
0
Published in 2019 at "Rheumatology"
DOI: 10.1093/rheumatology/kez577
Abstract: OBJECTIVE Using data from the German Biologics JIA Registry (BIKER), long-term safety of biologics for systemic-onset JIA with regard to adverse events of special interest was assessed. METHODS Safety assessments were based on adverse event…
read more here.
Keywords:
biker;
long term;
systemic onset;
data german ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2021-eular.2141
Abstract: Macrophage activation syndrome (MAS) is a severe life-threatening complication of the systemic-onset juvenile idiopathic arthritis (soJIA). The treatment options included high-dose of the corticosteroids (CS), cyclosporine A (CsA), intravenous immunoglobulin (IVIG) and biologics, predominantly IL-1…
read more here.
Keywords:
activation syndrome;
treatment;
macrophage activation;
systemic onset ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Frontiers in Pediatrics"
DOI: 10.3389/fped.2021.597458
Abstract: Background: Arthritis may occur after the diagnosis of Kawasaki disease (KD). Most cases are self-limiting; however, some patients require prolonged treatment. Method: To characterize KD-related arthritis, 14 patients who required arthritis treatment within 30 days…
read more here.
Keywords:
related arthritis;
japan;
kawasaki disease;
systemic onset ... See more keywords